A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances

A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances

Abstract Purpose Dim light vision disturbances (DLD) comprise a wide range of symptoms affecting the quality of vision at low illumination including glare, halos, and starbursts. This exploratory study investigated 1.0% phentolamine mesylate ophthalmic solution (PMOS) as a treatment to improve visio...

Full description

Bibliographic Details
Main Authors: Jay Pepose, Mitchell Brigell, Eliot Lazar, Curtis Heisel, Jonah Yousif, Kavon Rahmani, Ajay Kolli, Min Hwang, Cara Mitrano, Audrey Lazar, Konstantinos Charizanis, Mina Sooch, Marguerite McDonald
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Ophthalmology
Subjects:
Night Vision Disturbance
Dim Light Disturbance
Photic Phenomenon
Phentolamine
Halos
Glare
Online Access:https://doi.org/10.1186/s12886-022-02621-6

Internet

https://doi.org/10.1186/s12886-022-02621-6

Similar Items